Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.
Parliament Rejects Bill That Would End Driving Discrimination; Latham Jeers ‘Pass The Bong’
Parliament rejects the bill that would give medicinal cannabis patients equal rights on the road.Read more
A Recap of Our Successes and the Road Still Ahead
How the Drive Change campaign has made an impact on the unjust medicinal cannabis driving laws.Read more